From Go-Karts to Formula 1: Distinguishing True Digital Signatures
Digital signatures have grown in sophistication and import, becoming a staple of serious and compliant drug manufacturers, explains SAFE-Biopharma's Mollie Shields-Uehling. Read more »
Biotech Production: Planning, Scheduling & Throughput Analysis with Constraints, Lean and Simulation Approach
A major biotech company's only final stage bio-manufacturing facility in the struggles to meet customer demand. Read more »
Funny Pharm: Write the Cartoon Caption & Win
Introducing "Funny Pharm," sponsored by Paratherm Corp., featuring drawings by award-winning cartoonist Jerry King. Submit your caption and win. Read more »
Visit our Editor's Blog: On Pharma
We go behind consumer media headlines, beyond trade press boundaries, to offer candid analysis and commentary on issues affecting drug manufacturers. We cover the gamut, from fiscal to philosophical, from serious to silly. Read more »White Papers
- Handheld Raman Instruments for Pharmaceutical Raw Material Inspection: From the Lab to the Loading Dock The purpose of this paper is to discuss the application of Raman spectroscopy to the unique requirements of raw material testing. In order to do so we will answer the following questions: What is and why perform identity testing? What are the incentives to speed up testing? Should we consider modifying the testing process? How does the Thermo Scientific TruScan handheld Raman instrument perform ID testing? How well does TruScan work for common raw materials? Can this be deployed in a regulated pharmaceutical environment?
- Materials Safety and Analysis: Staying Lean, Compliant, and Cost-Effective
- Thermo Scientific TruScan Fast, Cost-Effective Method Development
- What Does Your Plant Spend on Raw Material Identity Verification? The Answer May Surprise You
- View more white papers »
Events Calendar
Keep track of upcoming events relevant to the pharmaceutical manufacturing industry. Visit our events calendar.
Industry Voices
- PharmaView: What's In Your Wastewater? It's Time to Find Out
- Digital Insights: “Presenteeism” From Afar: Is Your Vacation A Blackberry-Free Zone?
- Therapeutic Dose: Throwing out the Bathwater, the Baby, the Tub . . .
- On Pharma Blog: EZ Pass Testing, Coercion and Buck Passing: A Tale of Broken Pharma QA and QC. Sound familiar?
Product Center
View all products »
Syrris: Launches Glass Pressure Reactor SystemHielscher Ultrasonics: Brand New Glass Flow Cell for Ultrasonic Emulsifying
Thermo Fisher Scientific: Simplifies UV-Vis Spectroscopy, Streamlining QA/QC Processes with Launch of its Evolution 200 Series
Rotronic: HygroLog HL-20/21 Data Logger
Spiroflow Systems: Introduces Bulk Bag (FIBC) Discharger for the Pharma Industry
AccuPRO-ID: Microbial Identification - Confidence at Low Cost
Fluid Components International: ST51 Greenhouse Gas Flow Meter For Process & Plant Flue Gas Applications
3M: Integrated Dose by Dose Counter Receives FDA Approval
Ask The Experts
- An unusual reclaim processFilled product is recovered from dose checks or improperly stoppered vials, is dumped into a holding tank, in a class 100,000 area, and once in the tank, it is pumped back to the main product holding tank. It is mixed with the product in the holding tank, refiltered and filled again during the course of the filling operations. Wouldn't this "reclaim process" be considered a reworking of the product? Unless this process was submitted along with the ANDA originally, and validated, it seems that this would not be following good cGMP practice for sterile filling operations. I don't think FDA or any other regulatory agency would find this to be an acceptable practice. What are your thoughts?
- Encouraging new syringe designs internationallyWhat’s being done to encourage new types of syringe designs internationally?
- OEE vs. TEEPWhat is more important, Overall Equipment Effectiveness or Total Effective Equipment Performance (TEEP)?
- World-class OEE for finished goods manufacturingWhat is world-class OEE for pharmaceutical finished goods manufacturing?
- Challenge of bringing new syringe technologies to marketThere are lots of new syringes and injection devices available to manufacturers. What’s keeping them from being brought to market?
- Choosing the right NIR instrument for the applicationWhich is the "best" near-infrared instrument on the market?
- ROI from NIR What would be the first application I should attempt with Near-Infrared?
- Validation of QBD/PAT activitiesMy query is regarding the impact of “QBD/PAT” on Development Procedures: 1. What “Stability Studies Data” are expected by the regulatory agencies for a product/process developed through PAT/QBD? 2. What kind of Validation activities are proposed for the "established co-relation" between the "process parameters and composition of formula" with Product Quality Parameters?
Career Center
Recent Job Postings:
Create a Career Profile Put your anonymous Career Profile up today and employers will begin pitching you job opportunities.
Sign-up for Job Alerts Your personal Job Alerts notify you by email of new jobs posted that match your search preferences.
Utilize Career Resources Browse our content library, enlist the help of a trained career coach or simply ask an expert for career advice.
From the Editors
-
From the Editor: How Good is Your Data (And Can You Find It)?Forget, for the moment, about process understanding and control. How are you doing on basic document retrieval? -
PharmaView: What's In Your Wastewater? It's Time to Find OutWe have little grasp of the downstream impact of API's being discharged from our facilities. -
Digital Insights: “Presenteeism” From Afar: Is Your Vacation A Blackberry-Free Zone?Is your family vacation a blackberry-free zone? -
Therapeutic Dose: Throwing out the Bathwater, the Baby, the Tub . . .Big manufacturers have forgotten why they grew big in the first place, to the severe detriment of their PAT and QbD programs, says Contributing Editor Emil Ciurczak.
Resource Centers
Aseptic Processing
Articles
Continuous Low Moisture Wet Mass Granulation: A Demonstration of Potential
PDA 2010: A Glimpse into the Single-Use Future
Taking the Plunge to Harmonize Pharmaceutical Regulations
A Business Case for Isolation Technology
Agalloco: Can We Break Down the Isolation Barriers?
More articles »
White Papers
Cartridge Filtration in the Production of Pharma Grade Water
Six Key Predictors of Outsourcing Success In A Maturing RE & FM Outsourcing Market
Environmental Monitoring and Certification in Controlled Environments: Meeting Regulations and Achieving Effective Microbial Control for Pharmaceutical and Medical Device Manufacturers
Online UPLC Method for the Support of Cleaning Validation and the Routine Monitoring of Cleaning Procedures
More white papers »
Automation & Control
Articles
From Go-Karts to Formula 1: Distinguishing True Digital Signatures
Automating Microscope-Based Particle Counting
Taking Advantage of the USPTO's New Green Technology Pilot Program
Human Centered Design: The Coming Revolution
Failure Coding at Merck: A Model for Maintenance Success
More articles »
White Papers
Enhancing Collaboration with the FDA Through MedWatch Plus
Six Key Predictors of Outsourcing Success In A Maturing RE & FM Outsourcing Market
The Executive Guide to Contract and Chargeback Management: How Pharmaceutical Manufacturers Smartly Automate to Strengthen Profitability
Complying With U.S. FDA Title 21 CFR Part 11 for the Life Sciences Industry
More white papers »
cGMPs and Compliance
Articles
Pharma Water Everywhere, but Little Consistent Guidance
Afnan to FDA: Simplify Post-Approval Changes, Spur Innovation
Pharma's Changing Strategic Planning Landscape
Computer System Validation: Are You Ready for an Inspection?
PDA 2010: Quality Risk Management from Theory to Practice: The Cangene Experience
More articles »
Contract Manufacturing
Drug Delivery
Articles
Biotech Production: Planning, Scheduling and Throughput Analysis with a Combined Theory of Constraints, Lean and Simulation Approach
PDA 2010: Stopper Sensibility
Bringing More Science to Tableting
Taking the Plunge to Harmonize Pharmaceutical Regulations
Getting More Scientific About Tableting
More articles »
White Papers
Avoiding No Man's Land: Potential Unintended Consequences of Follow-On Biologics
Best Practices in Demand and Inventory Planning
SAP Support of the Healthcare Supply Chain’s Ongoing Effort to Ensure Patient Safety and Drive Business Value
Residual Solvents by HT3 Headspace in Reference to USP 467 with a Comparison of Static Versus Dynamic Headspace Analysis
More white papers »
Facilities & Support
Articles
Keeping Your Cool: Tips for Maintaining Your Cooling Towers
PharmaView: What's In Your Wastewater? It's Time to Find Out
Drugs in Wastewater: A Call for More Research, More Responsibility
Condition Monitoring: Try Not To Be Alarmed
Baxter's Los Angeles Bio Plant Wins Bronze Shingo Prize
More articles »
White Papers
Six Key Predictors of Outsourcing Success In A Maturing RE & FM Outsourcing Market
A Rapid and Sensitive UPLC/UV/MS Method for Simvastatin and Lovastatin in Support of Cleaning Validation Studies
Use of Universal HPLC Detection for Cleaning Validations
How to Prepare for an Inspection of Your Company's Information Integrity
More white papers »
Fill & Finish
Articles
Taking the Plunge to Harmonize Pharmaceutical Regulations
Getting More Scientific About Tableting
A Business Case for Isolation Technology
Putting Particulates on the Map
Pharma Facilities: Can One Patent Agility?
More articles »
White Papers
Cartridge Filtration in the Production of Pharma Grade Water
Increasing Tablet Press Productivity Using Segmented Turret Technology
Where and What to Test: From Purified Bulk Drug Substance to Sterile Liquid Final Drug Product
SAP Support of the Healthcare Supply Chain’s Ongoing Effort to Ensure Patient Safety and Drive Business Value
More white papers »
Industry Developments
Articles
Funny Pharm: You Write the Caption & Win: August-September 2010
Funny Pharm: You Write the Caption & Win: August 2010
Digital Insights: “Presenteeism” From Afar: Is Your Vacation A Blackberry-Free Zone?
Funny Pharm: You Write the Caption & Win: July/August 2010
Funny Pharm: You Write the Caption & Win: July 2010
More articles »
White Papers
A Fact-Based View of the Workforce: Essential to M&A Success
Enhancing Collaboration with the FDA Through MedWatch Plus
Biotech Responds to Dramatic Changes to Innovate in 2010 and Beyond
Six Key Predictors of Outsourcing Success In A Maturing RE & FM Outsourcing Market
More white papers »
Operational Excellence & Lean Six Sigma
Articles
How Lean is Pharma?: A 10-Year Progress Report
Lean Materials Management: Lessons from Lonza
Taking Advantage of the USPTO's New Green Technology Pilot Program
Toyota's Meltdown: Lessons for Pharma on its Lean Journey
Designing the Lean Quality System
More articles »
White Papers
The Lean Workforce: Applying Lean Principles to Improve Workforce Management
Part 2: Operational Excellence Programs in the Industry: A Tefen Series: OpEx in the Life Sciences
Part 3: Learning from the Industry: A Tefen Series: Operational Excellence in the Life Sciences
Part 1: State of the Industry: A Tefen Series: Operational Excellence in the Life Sciences
More white papers »
Packaging
Articles
How New Packaging Technologies are Helping in the Struggle Against Counterfeit Drugs
Supplier Audits: Drawing ROI from a Trusted Community
Webinar: Tackling Counterfeit Drugs with Serialization
PDA 2010: Stopper Sensibility
Taking the Plunge to Harmonize Pharmaceutical Regulations
More articles »
Process Operations
Articles
The Evolving LIMS, and What It Means for the Pharmaceutical Lab
Using RMM for Environmental Monitoring
Time and Cost Identified as Key Roadblocks to PAT and QbD; Experts Disagree
Connecting Data to the Patient: Paul McKenzie on J&J Pharma R&D's Lab-to-Patient Program
Therapeutic Dose: Throwing out the Bathwater, the Baby, the Tub . . .
More articles »
White Papers
Handheld Raman Instruments for Pharmaceutical Raw Material Inspection: From the Lab to the Loading Dock
Materials Safety and Analysis: Staying Lean, Compliant, and Cost-Effective
Thermo Scientific TruScan Fast, Cost-Effective Method Development
What Does Your Plant Spend on Raw Material Identity Verification? The Answer May Surprise You
More white papers »
Quality Assurance & Control
Articles
Drugs in Wastewater: A Call for More Research, More Responsibility
Time and Cost Identified as Key Roadblocks to PAT and QbD; Experts Disagree
How Lean is Pharma?: A 10-Year Progress Report
Therapeutic Dose: Throwing out the Bathwater, the Baby, the Tub . . .
What Pharmaceutical Quality Managers Need to Know About Calibration of Environmental Monitoring Systems
More articles »
Unit Operations
Articles
Keeping Your Cool: Tips for Maintaining Your Cooling Towers
Continuous Low Moisture Wet Mass Granulation: A Demonstration of Potential
Automating Microscope-Based Particle Counting
Streamlining Lyophilization Processes from the Start
Taking Advantage of the USPTO's New Green Technology Pilot Program
More articles »
Audio Update
- Focus on Pharma Episode 8: Pharmaceutical QbD: An Industry Progress Report Led By Ali Afnan Faster drug approvals, real-time release, regulatory relief. These, and many other benefits, are promised by adopting Pharmaceutical Quality by Design principles. So why aren't more people embracing the concept? Skeptics continue to see QbD efforts as too expensive, time consuming and impractical, while QbD and PAT projects are being launched separately, rather than together as intended. Exploring the reasons for this apparent disconnect, and potential solutions, are Ali Afnan, Pedro Hernandez-Abad, Sam Venugopal and Gawayne Mahboubian-Jones.
- From SharePoint to Cloud Computing: Microsoft's Life Sciences Evolution Microsoft is positioning SharePoint as a solution to the industry's innovation gap. In this interview with Senior Editor Paul Thomas at DIA 2010, Michael Naimoli, Director of Life Sciences Industry Solutions, discusses how manufacturers like GSK and Merck are using SharePoint as a knowledge management platform to find new ways to innovate.
- Podcast: API Pollution: Are Drug Manufacturers Trying to Stymie Studies? A recent U.S. Geological Survey study found two drug facilities in New York state releasing high levels of API into local groundwater. The manufacturers have been less than cooperative, says study lead Patrick Phillips, speaking with Senior Editor Paul Thomas. Without adequate studies, Phillips adds, there's no way of knowing what the impact of the compounds on local biota might be.
- Focus on Pharma Episode 7: J&J's Paul McKenzie on Data Transparency and Connecting to the Patient Paul McKenzie, global head of pharmaceutical development and manufacturing sciences at J&J Pharmaceutical Research and Development, discusses J&J's Lab to Patient program, and how the drug industry might connect its data silos to optimize results for the patient.
- Focus on Pharma Episode 6: Continuous Processing: Is Pharma Moving Beyond the Batch? Although batch manufacturing promises to dominate drug manufacturing, there are a growing number of opportunities to harness the power of continuous manufacturing. Is the industry reaching a tipping point? Bernhardt Trout, head of the Novartis-MIT Center for Continuous Manufacturing, shares his views on what is changing.
- Flowing Over: Continuous Manufacturing Finding a Home in Pharma The significant uptake of continuous processing in pharma coincides with technologies that enable it. Most of the technology gaps have been filled, says Microfluidics' CTO Mimi Panagiotou, PhD, who discusses why continuous processing is reaching a tipping point in pharma now, and various ways that manufacturers are using her company's MRT reactors for continuous crystallization and multi-phase reactions.
- Automating R&D Workflows, Searching for Step-Change Productivity Gains Freeslate is working with J&J and other pharma clients to automate and integrate diverse workflows within pharma labs and make analytical data more accessible to development scientists. We talk with CEO John Senaldi to get a better sense of his company's solutions, including the benefits of Lab Execution & Analysis (LEA) software.
- Continuous Processing: The Industry’s New Mindset Bernhardt Trout, head of the Novartis-MIT Center for Continuous Manufacturing, finally sees a tipping point in acceptance of continuous processing methods in pharma. Dr. Trout shares views on what’s changed, and what’s to come, in the continuous world.
How Lean is Pharma?: A 10-Year Progress Report
Controlled Release Moves Beyond Patent Extension
Using RMM for Environmental Monitoring
USP Updates
Funny Pharm: You Write the Caption & Win: August 2010
Funny Pharm: You Write the Caption & Win: August-September 2010
Sanofi CEO: Genzyme is 'Stonewalling'
Materials Safety and Analysis: Staying Lean, Compliant, and Cost-Effective
Hielscher Ultrasonics: Brand New Glass Flow Cell for Ultrasonic Emulsifying
Webinar: Staying One Step Ahead of the FDA: Supplier Audits and Ensuring Raw Material Quality
Webinar: Staying One Step Ahead of the FDA: Supplier Audits and Ensuring Raw Material Quality
Focus on Pharma Episode 8: Pharmaceutical QbD: An Industry Progress Report Led By Ali Afnan
Webcast: Best Practices Rapid Deployment for Pharmaceutical Manufacturing
From SharePoint to Cloud Computing: Microsoft's Life Sciences Evolution
Podcast: API Pollution: Are Drug Manufacturers Trying to Stymie Studies?
Get Connected Now!
Online Poll
Webcast Library
- Webinar: Staying One Step Ahead of the FDA: Supplier Audits and Ensuring Raw Material Quality To avoid costly shutdowns, product seizures, and warning letters, drug firms need effective raw material controls and critical supplier auditing procedures. Imagine how effective your controls would be if you were using the same exact field sampling techniques and tools FDA investigators use. If you'd like to learn some of the lessons the FDA has adopted in the wake of the contaminated Heparin and Glycerin scandals, then attend this webinar hosted by Thermo Fisher Scientific on Tuesday, September 14th.
- Webcast: As Your Markets Grow, Can Your Data Management Systems Keep Up? SAP is helping Life Science companies implement comprehensive and proven industry specific solutions that manage business processes in one preconfigured Life Science industry solution. Join us to learn how Convatec implemented an SAP Life Science industry solution using industry best practices and rapid deployment methodologies to meet an aggressive implementation timetable and develop a solid foundation to support future growth in the highly regulated Life Science Industry.
- Webcast: Applying Lean in the Lab Toyota methods may have been designed for the shop floor, but they are leading to significant improvements in the way pharmaceutical quality and even research labs operate. Hear leading consultants--Tadgh Prendeville, BSM USA and Bikash Chatterjee, Pharmatech Associates as well as Margaret Wyche, Director of QC, Allergan share their experiences on increasing efficiency, decreasing waste and improving quality in the lab.

Excellence by Design: Melissa Herkt on the The Case for PAT and QbD
BIO 2010: Kidding Around with Shionogi's Sico
Panel Discussion: Healthcare Reform and its Impact on the Biopharmaceutical Industry
CMO Searching: Just Point and Click?
German Biotech: The Pharma, Bio and Chem Connection
Single-Use Systems and Automation: An Unhappy Marriage?